Yanhua Xuan
Overview
Explore the profile of Yanhua Xuan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
428
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cho H, Jo S, Kim M, Kim H, Liu X, Xuan Y, et al.
Sci Rep
. 2023 Nov;
13(1):19885.
PMID: 37963940
The dosage-dependent recruitment of RNA polymerase II (Pol II) at the promoters of genes related to neurodevelopment and stem cell maintenance is required for transcription by the fine-tuned expression of...
2.
Che N, Li M, Liu X, Cui C, Gong J, Xuan Y
Phytomedicine
. 2023 Nov;
122:155144.
PMID: 37925889
Background: Colorectal cancer (CRC) metastasis is a complicated process that not only involves tumor cells but also the effects of M2 type tumor-associated macrophages, a key component of the tumor...
3.
Li M, Che N, Liu X, Xuan Y, Jin Y
Biochem Pharmacol
. 2023 Oct;
217:115838.
PMID: 37778445
M2 type tumor-associated macrophages, an essential component of the tumor microenvironment (TME), have been proved to contribute to tumor metastasis. Dauricine (Dau) has recently received widespread attention due to its...
4.
Li M, Che N, Feng Y, Liu X, Piao L, Xuan Y, et al.
Exp Mol Pathol
. 2022 Mar;
125:104755.
PMID: 35278461
Several studies have demonstrated that B7-H4 is highly expressed in a variety of cancers and often affects tumor development. However, its role in cancer stemness and epithelial-to-mesenchymal transition (EMT) in...
5.
Qian Y, Liu X, Feng Y, Li X, Xuan Y
Int J Urol
. 2022 Feb;
29(6):578-585.
PMID: 35218089
Objectives: Tenascin C is a potential biomarker of cancer-associated fibroblasts and has been significantly associated with poor prognosis in patients with prostate cancer. However, the effects of Tenascin C in...
6.
Yang Z, Zhang C, Liu X, Che N, Feng Y, Xuan Y
Am J Pathol
. 2022 Jan;
192(4):712-721.
PMID: 35063407
Although glycolysis plays a pivotal role in breast cancer stem-like cell (BCSC) reprogramming, the molecular mechanisms that couple glycolysis to cancer stem-like cells remain unclear. SETD5 is a previously uncharacterized...
7.
HBXIP accelerates glycolysis and promotes cancer angiogenesis via AKT/mTOR pathway in bladder cancer
Liu X, Li H, Che N, Zheng Y, Fan W, Li M, et al.
Exp Mol Pathol
. 2021 Jul;
121:104665.
PMID: 34216584
Abnormal metabolism and uncontrolled angiogenesis are two important characteristics of malignant tumors. Although HBXIP is known to be associated with a poor prognosis for bladder cancer (BC), its effects on...
8.
Feng Y, Yang Z, Zhang C, Che N, Liu X, Xuan Y
Pathol Res Pract
. 2021 Jan;
218:153323.
PMID: 33429327
B7-H4 is a unique negative regulator of T cells that is typically significantly overexpressed in various carcinomas and is associated with poor prognosis. However, the effects of B7-H4 expression on...
9.
Che N, Yang Z, Liu X, Li M, Feng Y, Zhang C, et al.
J Cell Mol Med
. 2020 Dec;
25(4):2110-2120.
PMID: 33314691
Leucine zipper-EF-hand-containing transmembrane protein 1 (LETM1) is a mitochondrial inner membrane protein that is highly expressed in various cancers. Although LETM1 is known to be associated with poor prognosis in...
10.
Piao L, Feng Y, Che N, Li M, Li X, Jin Y, et al.
Pathol Res Pract
. 2020 Nov;
216(12):153258.
PMID: 33130499
SETD8 is a lysine methyltransferase containing an SET domain and has been reported to regulate various biological processes, including carcinogenesis. However, its prognostic value and mechanisms of action in non-small...